Simply Wall St.
Why Madrigal Pharmaceuticals (MDGL) Is Down 9.7% After Rezdiffra’s Near US$1 Billion Debut Year
📊
AI Sentiment
Positive
7/10
Madrigal Pharmaceuticals Inc. News
Latest updates and market news for MDGL
1 news
Feb 25 - Mar 3, 2026
Page 1
Share this news page